Truscreen Group Ltd (NZSE:TRU) Share Price

Company Profile

Business description
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.
Contact
C/- HLB Mann Judd Limited
57 Symonds Street
Level 6, Equitable House
Grafton
Auckland1010
NZL
T: +64 93032243
https://www.truscreen.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2026
Employees
9

Recommended

Going back to my original thesis to evaluate a position.

Mark LaMonica, CFA | 08 August 2025

This company dominates its industry and could be flirting with regulatory intervention.

Roy Van Keulen | 07 August 2025

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.

Mark Giarelli | 07 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,076.60	25.40	-0.28%
CAC 40	7,743.00	33.68	0.44%
DAX 40	24,162.86	29.64	-0.12%
Dow JONES (US)	44,175.61	206.97	0.47%
FTSE 100	9,095.73	5.04	-0.06%
HKSE	24,858.82	222.81	-0.89%
NASDAQ	21,450.02	207.32	0.98%
Nikkei 225	41,820.48	761.33	1.85%
NZX 50 Index	12,844.63	42.47	-0.33%
S&P 500	6,389.45	49.45	0.78%
S&P/ASX 200	8,807.10	24.30	-0.28%
SSE Composite Index	3,635.13	4.54	-0.12%